Evidence map›Paper›PMID 25529135›Full record

ArticleArchives of biochemistry and biophysics2015

Design and characterization of a photo-activatable hedgehog probe that mimics the natural lipidated form.

Alan J House, Laura R Daye, Michael Tarpley, Kezia Addo, David S Lamson, Margie K Parker, Warren E Bealer, Kevin P Williams

Abstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alan J HouseDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Laura R DayeDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Michael TarpleyDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Kezia AddoDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
David S LamsonDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Margie K ParkerDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Warren E BealerDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Kevin P WilliamsDepartment of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA. Electronic address: kpwilliams@nccu.edu.

Funding

Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
RC3 Ethanol-Cannabinoid Interaction in the Regulation of NeurogenesisU54AA019765 · NIAAA · NORTH CAROLINA CENTRAL UNIVERSITY · PI COLE, GREGORY JAY · 2010 to 2019
$8.7M
Targeting DYRK1A Modulation of GLI1 for Anti-Tumor EfficacyR15CA208651 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI WILLIAMS, KEVIN PETER · 2016 to 2016
$376k
Identification of Specific Antagonists that Bind Hedgehog and Block its ActivityR15CA159209 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI WILLIAMS, KEVIN PETER · 2011 to 2011
$363k
NCI NIH HHS R15 CA159209NCI NIH HHS R15CA159209NCI NIH HHS R15 CA208651NCI NIH HHS U54 CA156735NCI NIH HHS U54CA156735NIAAA NIH HHS U54 AA019765NIAAA NIH HHS U54AA019765
6 · The paper itself

Abstract

We have generated a photoactivatable form of sonic hedgehog protein by modifying the N-terminal cysteine with the heterobifunctional photocrosslinker 4-maleimidobenzophenone (Bzm). The Bzm modification on ShhN imparted a significant increase in activity as assessed in the C3H10T1/2 functional assay with potency comparable to that of the endogenous dual-lipidated form of ShhN (ShhNp). Reversed-phase HPLC analysis indicated that the increase in activity compared to unmodified ShhN may be due in part to the hydrophobic nature of the benzophenone group. In contrast to the fully processed ShhNp, Bzm-ShhN is monomeric as assessed by analytical SEC and does not require detergent to be soluble. Further, we demonstrated that the Bzm-ShhN was able to crosslink in vitro in the presence of a known binding partner, heparin. We suggest that Bzm-ShhN can serve as a relatively facile and preferred source of ShhNp for in vitro assays and as a probe to identify novel Hh protein interactions.

Indexed as

Lipid MetabolismPhotochemical ProcessesAnimalsBenzophenonesBiomimetic MaterialsCell LineHedgehog ProteinsHeparinHumansMiceMolecular ProbesbenzophenoneBenzophenonesHedgehog ProteinsHeparinMolecular ProbesSHH protein, humanBenzophenoneCrosslinkingHeparinPalmitoylPhotoactivatableSonic hedgehog

Identifiers

PMID25529135
PMCPMC4322941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.